Go Pro
NYSE:AGL

Agilon Health (AGL) Stock Price, News & Analysis

Agilon Health logo
$88.08 +1.60 (+1.85%)
As of 09/4/2026 03:58 PM Eastern

About Agilon Health Stock (NYSE:AGL)

Advanced

Key Stats

Today's Range
$86.37
$88.74
50-Day Range
$86.47
$129.46
52-Week Range
$7.48
$133.04
Volume
125,897 shs
Average Volume
257,707 shs
Market Capitalization
$1.48 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$97.70
Consensus Rating
Hold

Company Overview

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs. It offers services such as utilization management, chronic‐care coordination and telehealth solutions, all designed to improve patient outcomes while controlling costs. By integrating these capabilities, Agilon helps physician partners navigate regulatory requirements and optimize performance under Medicare Advantage and other government-sponsored programs.

Founded in 2017 and headquartered in Newport Beach, California, Agilon Health has expanded into multiple U.S. markets, including California, Florida, Arizona, Ohio and Georgia. The company collaborates with physician groups across more than 140 counties, supporting tens of thousands of Medicare beneficiaries. Agilon’s growth has been driven by increasing demand for value-based care models that emphasize quality, efficiency and patient satisfaction.

Led by a team of healthcare executives with experience in medicine, insurance and technology, Agilon Health is committed to transforming primary care delivery. The company’s mission is to align financial incentives with patient health, fostering long-term partnerships with physicians and advancing the shift toward a more sustainable, outcome-focused healthcare system.

AI Generated. May Contain Errors.

Agilon Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
32nd Percentile Overall Score

AGL MarketRank™: 

Agilon Health scored higher than 32% of companies evaluated by MarketBeat, and ranked 745th out of 911 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Agilon Health has received a consensus rating of Hold. The company's average rating score is 2.21, and is based on no strong buy ratings, 5 buy ratings, 7 hold ratings, and 2 sell ratings.

  • Upside Potential

    Agilon Health has a consensus price target of $97.70, representing about 10.9% upside from its current price of $88.08.

  • Amount of Analyst Coverage

    Agilon Health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Agilon Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Agilon Health are expected to grow in the coming year, from ($2.33) to ($0.24) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Agilon Health is -6.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Agilon Health is -6.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Agilon Health has a P/B Ratio of 6.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Agilon Health's valuation and earnings.
  • Percentage of Shares Shorted

    5.98% of the float of Agilon Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Agilon Health has a short interest ratio ("days to cover") of 1.95, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Agilon Health has recently increased by 12.22%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Agilon Health does not currently pay a dividend.

  • Dividend Growth

    Agilon Health does not have a long track record of dividend growth.

  • News Sentiment

    Agilon Health has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Agilon Health this week, compared to 7 articles on an average week.
  • Search Interest

    7 people have searched for AGL on MarketBeat in the last 30 days. This is an increase of 133% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Agilon Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.50% of the stock of Agilon Health is held by insiders.

  • Percentage Held by Institutions

    Agilon Health has minimal institutional ownership at this time.

  • Read more about Agilon Health's insider trading history.
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilon Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AGL Stock News Headlines

Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
Agilon Health (AGL) Q2 2026 Earnings Call Transcript
See More Headlines

AGL Stock Analysis - Frequently Asked Questions

Agilon Health's stock was trading at $17.2125 at the beginning of the year. Since then, AGL shares have increased by 411.7% and is now trading at $88.08.

Agilon Health, Inc. (NYSE:AGL) released its quarterly earnings results on Wednesday, August, 5th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.90. The firm had revenue of $1.49 billion for the quarter, compared to analysts' expectations of $1.45 billion. Agilon Health had a negative trailing twelve-month return on equity of 119.38% and a negative net margin of 3.92%.
Read the conference call transcript
.

Shares of Agilon Health reverse split on Tuesday, March 31st 2026.The 1-25 reverse split was announced on Wednesday, March 18th 2026. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Agilon Health (AGL) raised $1 billion in an initial public offering (IPO) on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

Top institutional shareholders of Agilon Health include Rubicon Founders LLC (0.63%), Bank of New York Mellon Corp (0.21%), California State Teachers Retirement System (0.11%) and Great Lakes Advisors LLC (0.04%). Insiders that own company stock include John William Wulf, Benjamin Shaker, Karen Mcloughlin, Steven Sell, Diana Mckenzie, Jeffrey A Schwaneke and Timothy Gertsch.
View institutional ownership trends
.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agilon Health investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
8/05/2026
Today
9/05/2026
Wells Fargo 21st Annual Healthcare Conference
9/09/2026
Healthcare Services and Technology Conference
9/14/2026
Deutsche Bank 2026 Healthcare Summit
9/16/2026
Next Earnings (Estimated)
11/03/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:AGL
CIK
1831097
Fax
N/A
Employees
1,076
Year Founded
2016

Price Target and Rating

High Price Target
$146.00
Low Price Target
$48.00
Potential Upside/Downside
+10.9%
Consensus Rating
Hold
Rating Score (0-4)
2.21
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
($14.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$391.35 million
Net Margins
-3.92%
Pretax Margin
-4.23%
Return on Equity
-119.38%
Return on Assets
-16.85%

Debt

Debt-to-Equity Ratio
0.07
Current Ratio
1.08
Quick Ratio
1.08

Sales & Book Value

Annual Sales
$5.93 billion
Price / Sales
0.25
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$13.55 per share
Price / Book
6.50

Miscellaneous

Outstanding Shares
16,790,000
Free Float
16,371,000
Market Cap
$1.48 billion
Optionable
Not Optionable
Beta
3.02

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NYSE:AGL) was last updated on 9/5/2026 by MarketBeat.com Staff.
From Our Partners